Nanobac Pharmaceuticals, Incorporated (NNBP)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jan 12, 2026
Nanobac Pharmaceuticals Statistics
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
NNBP has 249.51 million shares outstanding.
| Current Share Class | 249.51M |
| Shares Outstanding | 249.51M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +1.17% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.01 |
| PB Ratio | -0.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.00
| Current Ratio | 0.00 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -4.52 |
| Interest Coverage | -23.72 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -36.84% |
| Return on Invested Capital (ROIC) | -95.31% |
| Return on Capital Employed (ROCE) | -934.85% |
| Weighted Average Cost of Capital (WACC) | 3.57% |
| Revenue Per Employee | 17,621 |
| Profits Per Employee | -6.58M |
| Employee Count | 1 |
| Asset Turnover | 0.00 |
| Inventory Turnover | 0.38 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | -50.12 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 47.21 |
| Average Volume (20 Days) | 144,968 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.06 |
Income Statement
In the last 12 months, NNBP had revenue of 17,621 and -6.58 million in losses. Loss per share was -0.03.
| Revenue | 17,621 |
| Gross Profit | 3,102 |
| Operating Income | -4.43M |
| Pretax Income | -6.58M |
| Net Income | -6.58M |
| EBITDA | -3.97M |
| EBIT | -4.43M |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 3,933 in cash and 4.12 million in debt, with a net cash position of -4.12 million or -0.02 per share.
| Cash & Cash Equivalents | 3,933 |
| Total Debt | 4.12M |
| Net Cash | -4.12M |
| Net Cash Per Share | -0.02 |
| Equity (Book Value) | -2.36M |
| Book Value Per Share | -0.01 |
| Working Capital | -6.71M |
Cash Flow
In the last 12 months, operating cash flow was -910,886 and capital expenditures -1,533, giving a free cash flow of -912,419.
| Operating Cash Flow | -910,886 |
| Capital Expenditures | -1,533 |
| Free Cash Flow | -912,419 |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | 17.60% |
| Operating Margin | -25,162.09% |
| Pretax Margin | -37,319.74% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NNBP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.95% |
| Shareholder Yield | -22.95% |
| Earnings Yield | -2,630,444.40% |
| FCF Yield | -364,967.60% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NNBP has an Altman Z-Score of -7.55 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.55 |
| Piotroski F-Score | 1 |